In another study, involving oral administration of captopril to A/J mice infected acutely with T. cruzi, Leon and co-workers reported that the acute myocarditis was ameliorated by prolonged treatment with this anti-hypertensive drug [3]. Although captopril is administrated routinely to hypertensive patients with chagasic cardiomyopathy, the immunological effects of this ACE inhibitor were not investigated systematically in humans. Our results revealed that ACE inhibitors potentiate T. cruzi infection of human monocytes, decreases the expression of the modulatory cytokine IL-10 while inducing Th17 cells. These studies suggest that anti-hypertensive

therapy based on captopril administration potentially alters the host–parasite balance

and might influence PFT�� ic50 the outcome of Chagas disease. The donors included in our studies were non-chagasic individuals (n = 6) from the state of Minas Gerais, Brazil, with average ages ranging between 25 and 32 years. We excluded from our study individuals with any chronic inflammatory disease, diabetes, heart and circulatory illnesses (including hypertension) or bacterial infections. All individuals included in this work were volunteers. This study is part of an extended project evaluating cardiac risk factors in Chagas disease and has the approval of the Ethical Committee of Universidade PF-6463922 cell line Federal de Minas Gerais in accordance with the Declaration of Helsinki. Tissue-culture

derived trypomastigotes (TCT) of the Y strain of T. cruzi were isolated from infected monolayers of Vero cells, as described previously Glutamate dehydrogenase [18]. Briefly, Vero cells were infected using five TCT/host cells and kept in RPMI-1640 enriched with 5% fetal calf serum (FCS), supplemented with antibiotics (penicillin at 500 U/ml and streptomycin at 0·5 mg/ml). After approximately 5 days, the TCT were collected from the supernatant, washed once by centrifugation with phosphate-buffered saline (PBS) pH 7·2 at 1000 g for 10 min at 4°C and resuspended in RPMI-1640 to a concentration of 5 × 107 TCT/ml. Peripheral blood mononuclear cells (PBMC) were purified as performed previously by us [18]. Briefly, heparinized blood was diluted 1:1 with PBS and applied over a Ficoll gradient. The mixture was centrifuged for 40 min at 600 g and PBMC were collected at the interface between the plasma and the Ficoll. Cells were washed three times by centrifugation with PBS and resuspended in RPMI-1640 supplemented with antibiotic/anti-mycotic (0·25 µg of amphotericin B/ml, 200 U of penicillin/ml, 0·1 mg of streptomycin/ml) and 1 mm l-glutamine at a concentration of 107 cells/ml. To obtain adherent cells, 2 × 106 PBMC/well were plated on 13-mm round coverslips in RPMI-1640 supplemented with 10% FCS and cultured in 24-well plates for 1 h at 37°C, 5% CO2.